ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
9.65
-0.54 (-5.30%)
Apr 28, 2026, 4:00 PM EDT - Market closed
ORIC Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 968 | 797 | 569 | 502 | 265 | 579 | |
| Market Cap Growth | 216.36% | 39.89% | 13.47% | 89.55% | -54.26% | -53.31% | |
| Enterprise Value | 694 | 517 | 307 | 285 | 84 | 302 | |
| Last Close Price | 9.65 | 8.18 | 8.07 | 9.20 | 5.89 | 14.70 | |
| PB Ratio | 2.47 | 2.07 | 2.34 | 2.24 | 1.19 | 2.12 | |
| P/TBV Ratio | 2.52 | 2.07 | 2.34 | 2.24 | 1.19 | 2.12 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.04 | 0.05 | 0.05 | 0.05 | |
| Net Debt / Equity Ratio | -0.71 | -0.71 | -1.01 | -0.88 | -0.87 | -0.82 | |
| Net Debt / EBITDA Ratio | 1.93 | 1.93 | 1.74 | 1.80 | 2.26 | 2.88 | |
| Net Debt / FCF Ratio | 2.45 | 2.45 | 2.17 | 2.29 | 2.52 | 3.71 | |
| Quick Ratio | 13.79 | 13.79 | 10.30 | 10.18 | 13.41 | 15.64 | |
| Current Ratio | 14.13 | 14.13 | 10.56 | 10.39 | 13.68 | 15.88 | |
| Return on Equity (ROE) | -41.27% | -41.27% | -54.73% | -45.11% | -35.98% | -27.98% | |
| Return on Assets (ROA) | -26.17% | -26.17% | -33.95% | -27.74% | -19.87% | -16.50% | |
| Return on Capital Employed (ROCE) | -36.80% | -36.80% | -57.30% | -47.80% | -37.40% | -27.80% | |
| Earnings Yield | -13.37% | -16.25% | -22.45% | -20.06% | -33.66% | -13.60% | |
| FCF Yield | -11.53% | -14.02% | -19.99% | -17.24% | -29.17% | -10.45% | |
| Buyback Yield / Dilution | -25.91% | -25.91% | -35.52% | -29.74% | -4.48% | -72.97% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.